Skip to main content

Table 3 Cumulative survival rates of patients in which the 4 lung cancer resection guidelines were or were not followed

From: Survival analysis of patients with non-small cell lung cancer who underwent surgical resection following 4 lung cancer resection guidelines

 

1-year

3-year

5-year

P

Overall

0.86 (0.84, 0.87)

0.60 (0.58, 0.62)

0.45 (0.42, 0.47)

 

IASLC guidelines

   

<0.001*

 Yes

0.90 (0.88, 0.92)

0.69 (0.66, 0.71)

0.51 (0.48, 0.54)

 

 No

0.85 (0.84, 0.87)

0.53 (0.58, 0.58)

0.41 (0.38, 0.44)

 

ACOSOG guidelines

   

<0.001*

 Yes

0.88 (0.86, 0.9)

0.64 (0.61, 0.66)

0.47 (0.44, 0.49)

 

 No

0.82 (0.79, 0.84)

0.55 (0.52, 0.58)

0.42 (0.38, 0.45)

 

RADIANT guidelines

   

<0.001*

 Yes

0.88 (0.86, 0.89)

0.62 (0.6, 0.64)

0.46 (0.43, 0.49)

 

 No

0.79 (0.75, 0.82)

0.53 (0.49, 0.57)

0.40 (0.35, 0.44)

 

NCCN guidelines

   

<0.001*

 Yes

0.88 (0.86, 0.90)

0.64 (0.61, 0.66)

0.47 (0.44, 0.49)

 

 No

0.82 (0.79, 0.84)

0.55 (0.52, 0.58)

0.42 (0.38, 0.45)

 
  1. ACOSOG, American College of Surgeons Oncology Group; IASLC, International Association for the Study of Lung Cancer (IASLC); NCCN, National Comprehensive Cancer Network; RADIANT, OSI Pharmaceutical’s RADIANT study; CI, confidence interval.
  2. Results are presented as cumulative survival rate (0.0-1.0) with corresponding 95% CI.
  3. *Significant difference between Yes/No follow guidelines, P < 0.05.